David O. Watson, General Counsel at Apellis Pharmaceuticals, Inc. (APLS), sold 10,000 shares at $24.49 ($245K) on 2025-12-16, disclosed to the SEC on 2025-12-18.
Scheduled sale ($245k) by General Counsel under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $24.49 | 5,000 | $122K | 50.0% |
| 2 | $24.49 | 5,000 | $122K | 50.0% |
| Total | $24.49 avg | 10,000 | $245K | 100% |
| Filing → |
| APLS | SELL | 2026-01-15 | $128K | — | Filing → |
| APLS | SELL | 2025-11-18 | $100K | — | Filing → |
| APLS | SELL | 2025-10-17 | $126K | — | Filing → |